San Antonio, Texas Clinical Trials

A listing of San Antonio, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized controlled trial of long-term (one year) prevention with eRapa versus placebo. The primary hypothesis is that eRapa decreases the risk of cancer relapse for patients with …

UT Health San Antonio
 (7.2 away) Contact site
  • 2 views
  • 19 Feb, 2024
  • 1 location
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

TTI-Methodist (Texas Transplant Institute) (SCRI)
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400011
 (0.4 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
body mass index
tirzepatide
dulaglutide
South Texas Veterans Administration Health Care
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

cancer therapy
measurable disease
durvalumab
endometrial cancer
cancer treatment
Research Site
 (10.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

gonadotropin
bilateral orchidectomy
testosterone
enzalutamide
gonadorelin
South Texas Accelerated Research Therapeutics
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
A Study of SGN-B6A in Advanced Solid Tumors

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether …

ovarian ca
measurable disease
small cell lung cancer
squamous cell carcinoma of head and neck
solid tumour
South Texas Accelerated Research Therapeutics
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic Dermatitis

This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

Aclaris Investigational Site
 (5.4 away) Contact site
  • 0 views
  • 23 Jan, 2025
  • +4 other locations
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

gonadotropin
screening procedures
HER2
measurable disease
human chorionic gonadotropin
South Texas Accelerated Research Theraputics (START), LLC
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
A First-in-human Study Using BDC-1001 in Advanced and HER2-Expressing Solid Tumors

A first-in-human study using BDC-1001 in HER2 expressing advanced malignancies

HER2
measurable disease
advanced solid tumor
cancer
solid tumour
Bolt Investigative Site
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations